TupeloLife Digital Therapeutics to Incorporate American Heart Association Digital Science
The American Heart Association’s CarePlans aim to improve heart health outcomes.
DALLAS, TEXAS, USA, June 14, 2021 /EINPresswire.com/ – It is estimated that about half of American adults have high blood pressure, with around 37 million people living with uncontrolled hypertension. High Blood Pressure Costs America’s Health Care System Over $ 131 Billion A Year. Today, TupeloLife Digital Therapeutics adds the American Heart Association’s science-based health management plans called CarePlans to their Precision Care Platform, a system of care that includes cellular monitoring technology. remote from patients and interactive artificial intelligence, to help patients work towards better management of chronic hypertension.
The American Heart Association has defined ideal cardiovascular health based on seven common risk factors, Life’s Simple 7®, which people can improve by making lifestyle changes: smoking, physical activity, weight, diet, blood sugar, cholesterol and blood pressure. The Association’s CarePlans outline actions people can take to improve the 7 Factors of Their Simple Lives and are designed so that everyone can work towards better health. Actions aren’t expensive or difficult, and even modest improvements in these factors can make a big difference.
“Every person deserves the opportunity to lead a full and healthy life. The Association’s Scientific CarePlans leverage cutting-edge science from the American Heart Association to improve health education and health engagement, ”said Eric Peterson, MD, MPH, vice-president and senior associate dean for clinical research at the university. from Southwest Texas and Chairman of the Health Tech Advisory Group for the American Heart Association’s Center for Health Technology and Innovation.
TupeloLife Digital Therapeutics has joined the Innovators Network of the American Heart Association’s Center for Health Technology and Innovation, which focuses on building and promoting relationships with health technologies to develop innovative solutions and scalable.
“This effort represents the convergence of medical science and technology. The Association’s Heart Health CarePlans provide science-based health management plans to help people better manage chronic conditions, such as hypertension, ”said Melvin Mathew, CEO and Founder of TupeloLife Digital Therapeutics. “By integrating these CarePlans into our platform, people who use our self-monitoring cell blood pressure monitors, blood glucose monitors and scales can learn specific actions they can take to help improve their health.
About TupeloLife Digital Therapeutics
TupeloLife is a digital therapy company working on the convergence of technology and science to reduce healthcare costs, improve access to healthcare, and improve health outcomes for populations with chronic diseases. TupeloLife Digital Therapeutics provides remote patient monitoring and telehealth services to healthcare systems, clinics, doctor’s offices and employer wellness programs.
Used in conjunction with TupeloLife Digital Therapeutics ‘cellular remote patient monitoring devices (a blood pressure monitor, blood glucose meter and scale), TupeloLife Digital Therapeutics’ Precision Care platform provides clinicians with secure access to patient data. to monitor and respond appropriately. The platform also includes the Association’s CarePlans with the aim of encouraging patients to better manage their hypertension through behavior change.
For more information, please visit tupelolife.com
CONTACT WITH THE MEDIA:
 Centers for Disease Control and Prevention (CDC). Hypertension Cascade: Estimates of the Prevalence, Treatment, and Control of Hypertension in U.S. Adults Aged 18 and Older Using Criteria from the American College of Cardiology and the American Heart Association’s 2017 Hypertension Guideline — NHANES 2013-2016external icon. Atlanta, GA: US Department of Health and Human Services; 2019.
 Kirkland EB, Heincelman M, Bishu KG, et. Al. Health expenditure trends among American adults with hypertension: National estimates, 2003-2014. J Am Heart Assoc. 2018; 7: e008731.
TupeloLife digital therapy
write us here
Visit us on social networks: